The influence of the BCR::ABL1 transcript type in CML still remains controversial, also due to technical bias, which could be bypassed by turning into alternative technologies, such as digital PCR (dPCR). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.